Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-01-23 Sale |
2023-01-23 5:10 pm |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
228 | $43.8 | $9,986 | 14,146 (Direct) |
View |
2023-01-19 Sale |
2023-01-20 4:05 pm |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
938 | $43.9 | $41,182 | 14,374 (Direct) |
View |
2022-10-24 Sale |
2022-10-25 4:00 pm |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
656 | $19.45 | $12,756 | 14,931 (Direct) |
View |
2022-07-22 Sale |
2022-07-25 4:12 pm |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
657 | $24.21 | $15,908 | 15,587 (Direct) |
View |
2022-04-22 Sale |
2022-04-25 4:38 pm |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
655 | $33.22 | $21,758 | 16,008 (Direct) |
View |
2022-01-24 Sale |
2022-01-25 4:39 pm |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
1,688 | $24.94 | $42,094 | 16,663 (Direct) |
View |
2021-10-22 Sale |
2021-10-25 6:30 pm |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
312 | $29.1 | $9,079 | 7,355 (Direct) |
View |
2021-07-22 Sale |
2021-07-26 4:05 pm |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
313 | $32.21 | $10,081 | 7,667 (Direct) |
View |
2021-06-24 Sale |
2021-06-28 4:01 pm |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
16,300 | $36.32 | $591,986 | 73,017 (Direct) |
View |
2021-04-22 Sale |
2021-04-26 6:13 pm |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
312 | $32.16 | $10,033 | 7,849 (Direct) |
View |
2021-03-31 Sale |
2021-04-02 8:55 pm |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
1,726 | $35.24 | $60,816 | 27,361 (Direct) |
View |
2021-01-22 Sale |
2021-01-25 5:44 pm |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
110 | $34.62 | $3,808 | 33,032 (Direct) |
View |
2020-10-22 Sale |
2020-10-23 4:19 pm |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
89 | $34.71 | $3,089 | 3,781 (Direct) |
View |
2020-09-08 Sale |
2020-09-10 8:54 pm |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
4,000 | $45.55 | $182,200 | 23,370 (Direct) |
View |
2020-07-22 Sale |
2020-07-23 4:23 pm |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
91 | $25.8 | $2,348 | 4,370 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-13 Option Award |
2025-02-18 4:30 pm |
N/A 2035-02-13 |
Neumora Therapeutics Inc. | NMRA | Duncan Jason See Remarks |
900,000 | $0 | 900,000 (Direct) |
View |
2023-12-11 Option Award |
2023-12-12 6:16 pm |
N/A 2033-12-10 |
Neumora Therapeutics Inc. | NMRA | Duncan Jason Chief Legal Officer |
400,000 | $0 | 400,000 (Direct) |
View |
2023-03-02 Equity Swap |
2023-03-02 4:44 pm |
N/A N/A |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
3,296 | $0 | 0 (Direct) |
View |
2023-01-19 Option Award(A) |
2023-01-27 5:26 pm |
N/A N/A |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
55,000 | $0 | 69,146 (Direct) |
View |
2023-01-19 Option Award |
2023-01-25 8:09 pm |
N/A N/A |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
55,000 | $0 | 69,146 (Direct) |
View |
2022-01-18 Option Award |
2022-01-20 4:52 pm |
N/A 2032-01-17 |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
26,700 | $0 | 34,251 (Direct) |
View |
2021-06-24 Exercise |
2021-06-28 4:01 pm |
N/A N/A |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
7,163 | $24.67 | 73,017 (Direct) |
View |
2021-06-24 Exercise |
2021-06-28 4:01 pm |
N/A N/A |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
9,137 | $24.04 | 73,017 (Direct) |
View |
2021-06-24 Exercise |
2021-06-28 4:01 pm |
N/A 2029-01-21 |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
16,300 | $0 | 73,017 (Direct) |
View |
2021-04-01 Exercise |
2021-04-02 8:55 pm |
N/A N/A |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
300 | $24.04 | 27,361 (Direct) |
View |
2021-04-01 Exercise |
2021-04-02 8:55 pm |
N/A 2029-01-21 |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
300 | $0 | 27,361 (Direct) |
View |
2021-01-21 Option Award |
2021-01-25 5:44 pm |
N/A 2031-01-20 |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
29,200 | $0 | 33,032 (Direct) |
View |
2020-09-08 Exercise |
2020-09-10 8:54 pm |
N/A N/A |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
3,500 | $24.04 | 23,370 (Direct) |
View |
2020-09-08 Exercise |
2020-09-10 8:54 pm |
N/A 2029-01-21 |
ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC |
3,500 | $0 | 23,370 (Direct) |
View |